Dylan Rodner
Medical · East Syracuse, NYNPI 1669599882
Payments from drug & device makers
Across 63 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$315
- Lilly USA, LLC$138
- GSK$69
- AstraZeneca$68
- Amgen$64
- Pfizer$59
- plus $383 from 14 others
What the payments were for
- Food & beverage$1,098100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 20 | $315 |
| Lilly USA, LLC | 8 | $138 |
| GSK | 4 | $69 |
| AstraZeneca | 4 | $68 |
| Amgen | 4 | $64 |
| Pfizer | 4 | $59 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| AbbVie | 2 | $39 |
| Boehringer Ingelheim | 2 | $37 |
| Exact Sciences | 2 | $34 |
| Corcept Therapeutics | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $32 |
| Kyowa Kirin, Inc. | 1 | $27 |
| Seqirus USA Inc | 1 | $24 |
| Merck | 1 | $24 |
| Bayer | 1 | $23 |
| BETA Bionics, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $20 |
| Cequr Corporation | 1 | $16 |
| Tolmar, Inc. | 1 | $13 |
How this compares
$1,098 in reported general payments places this provider in the 65th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 48 | $78,204 |
| OzempicSemaglutide | 53 | $68,170 |
| JanuviaSitagliptin Phosphate | 37 | $60,775 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $55,006 |
| EliquisApixaban | 34 | $47,220 |
| JardianceEmpagliflozin | 21 | $35,193 |
| TrulicityDulaglutide | 16 | $21,366 |
| MounjaroTirzepatide | 13 | $17,294 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 21 | $10,740 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $10,116 |
| PaxlovidNirmatrelvir/Ritonavir | 23 | $4,188 |
| Arnuity ElliptaFluticasone Furoate | 11 | $4,108 |
| Atorvastatin Calcium | 324 | $3,943 |
| Rosuvastatin Calcium | 178 | $3,380 |
| Duloxetine Hcl | 77 | $2,662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta | $69 | $79,96983 claims |
| AstraZenecaFarxiga | $68 | $78,20448 claims |
| Novo NordiskOzempic | $315 | $68,17053 claims |
| MerckJanuvia | $24 | $60,77537 claims |
| PfizerEliquis, Paxlovid | $59 | $51,40857 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $138 | $38,65929 claims |
| Boehringer IngelheimJardiance | $37 | $35,19321 claims |
| AbbVieSynthroid | $39 | $2,08721 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,395 medical providers in New York.
Other medical in East Syracuse
- Maggie GarlandEast Syracuse$18K
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.